This contract expires in 322 days (Jul 31, 2027).

Browse related active opportunities

NO SET ASIDE USED.

AZENTA US INC - A NEW AWARD TO SUPPORT THE RESEARCH MOLECULAR CHARACTERIZATION GOALS OF THE CHILDHOOD CANCER DATA INITIATIVE (CCDI) TO IMPROVE DIAGNOSIS AND TREATMENT FOR CHILDHOOD AND ADOLESCENT AND YOUNG ADULT (AYA) CANCERS.

PIID: 75N91025C00001Solicitation ID: 75N91023R00042
Signed Date: Dec 2, 2024Effective Date: Dec 2, 2024End Date: Closes in 322 days
Award $
$14.3M
Vendor
AZENTA US INC
NAICS
541380
Signed Date
Dec 2, 2024

Key Details

Dollars Obligated
$14.3M
Base & All Options
$35.0M
Awarding Sub-Agency
National Institutes of Health
Product Service Code
Q301 - REFERENCE LABORATORY TESTING
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
2
Place of Performance
SOUTH PLAINFIELD, NJ

Description

A NEW AWARD TO SUPPORT THE RESEARCH MOLECULAR CHARACTERIZATION GOALS OF THE CHILDHOOD CANCER DATA INITIATIVE (CCDI) TO IMPROVE DIAGNOSIS AND TREATMENT FOR CHILDHOOD AND ADOLESCENT AND YOUNG ADULT (AYA) CANCERS.

Context & Analysis

On Dec 2, 2024, Department of Health and Human Services obligated $14,258,500 to AZENTA US INC for a new award to support the research molecular characterization goals of the childhood cancer data initiative (ccdi) to improve diagnosis and treatment for childhood and adolescent and young adult (aya. The award is classified under NAICS 541380 — TESTING LABORATORIES AND SERVICES. Competition extent: full and open competition with 2 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in SOUTH PLAINFIELD, NJ. The contract is scheduled through Jul 31, 2027 — approximately 11 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541380 — related awards are listed below.

Contractor Information

Contractor: AZENTA US INC
UEI: FW1MQC5H7K56
Location: INDIANAPOLIS, IN

Stay Updated

Get notified about new opportunities matching your interests.

Related